DK379986D0 - Flydende vandigt praeparat af en 2-amino-5-oxo-5h-(1)-benzopyran(2,3-b)-pyridin-3-karboxylsyre - Google Patents

Flydende vandigt praeparat af en 2-amino-5-oxo-5h-(1)-benzopyran(2,3-b)-pyridin-3-karboxylsyre

Info

Publication number
DK379986D0
DK379986D0 DK379986A DK379986A DK379986D0 DK 379986 D0 DK379986 D0 DK 379986D0 DK 379986 A DK379986 A DK 379986A DK 379986 A DK379986 A DK 379986A DK 379986 D0 DK379986 D0 DK 379986D0
Authority
DK
Denmark
Prior art keywords
benzopyran
oxo
pyridine
amino
carboxylic acid
Prior art date
Application number
DK379986A
Other languages
English (en)
Other versions
DK166757B1 (da
DK379986A (da
Inventor
Hisayoshi Shimizu
Mitsuaki Oshima
Hideo Terayama
Original Assignee
Takeda Chemical Industries Ltd
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd, Senju Pharma Co filed Critical Takeda Chemical Industries Ltd
Publication of DK379986D0 publication Critical patent/DK379986D0/da
Publication of DK379986A publication Critical patent/DK379986A/da
Application granted granted Critical
Publication of DK166757B1 publication Critical patent/DK166757B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK379986A 1985-08-19 1986-08-08 Flydende vandigt praeparat af en 2-amino-5-oxo-5h-(1)-benzopyran(2,3-b)-pyridin-3-karboxylsyre DK166757B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18238385 1985-08-19
JP18238385 1985-08-19

Publications (3)

Publication Number Publication Date
DK379986D0 true DK379986D0 (da) 1986-08-08
DK379986A DK379986A (da) 1987-02-20
DK166757B1 DK166757B1 (da) 1993-07-12

Family

ID=16117350

Family Applications (1)

Application Number Title Priority Date Filing Date
DK379986A DK166757B1 (da) 1985-08-19 1986-08-08 Flydende vandigt praeparat af en 2-amino-5-oxo-5h-(1)-benzopyran(2,3-b)-pyridin-3-karboxylsyre

Country Status (10)

Country Link
US (1) US4728509A (da)
EP (1) EP0213514B1 (da)
JP (1) JPS62123116A (da)
AT (1) ATE53944T1 (da)
CA (1) CA1269618A (da)
DE (1) DE3672097D1 (da)
DK (1) DK166757B1 (da)
IE (1) IE59425B1 (da)
MY (1) MY102075A (da)
NO (1) NO171005C (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629639D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
GB8629640D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
US4778810A (en) * 1987-01-08 1988-10-18 Nastech Pharmaceutical Co., Inc. Nasal delivery of caffeine
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
ES2012532A6 (es) * 1988-07-15 1990-04-01 Cusi Lab Un procedimiento para la preparacion de una solucion acuosa de b-metil-4-(2' -tienilcarbonil)fenilacetato de lisina para aplicacion topica oftalmica.
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
JPH0714872B2 (ja) * 1990-02-06 1995-02-22 昭和薬品化工株式会社 シロップ剤組成物
US5602112A (en) * 1992-06-19 1997-02-11 Supergen, Inc. Pharmaceutical formulation
US20040014695A1 (en) * 1992-06-19 2004-01-22 Supergen, Inc. Pharmaceutical formulation
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
CA2121723A1 (en) * 1993-04-22 1994-10-23 Yoshifumi Ikejiri Aqueous agent
US5519030A (en) * 1993-10-07 1996-05-21 Senju Pharmaceutical Co., Ltd. Method for prophylaxis and treatment of myopia
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
US5824668A (en) * 1996-11-07 1998-10-20 Supergen, Inc. Formulation for administration of steroid compounds
KR980008226A (ko) * 1996-07-05 1998-04-30 다케다 쿠니오 시각기능장애의 예방 및 치료제
US6133248A (en) * 1997-06-13 2000-10-17 Cydex, Inc. Polar drug of prodrug compositions with extended shelf-life storage and a method of making thereof
US20040152664A1 (en) * 1998-09-02 2004-08-05 Allergan, Inc. Prednisolone compositions
JP2002523475A (ja) * 1998-09-02 2002-07-30 アラーガン・セイルズ・インコーポレイテッド 防腐したシクロデキストリン含有組成物
JP2001125052A (ja) * 1999-10-25 2001-05-11 Lion Corp コンタクトレンズ装着液
KR100791871B1 (ko) * 2000-06-19 2008-01-07 산텐 세이야꾸 가부시키가이샤 방부제
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
EP2522365B1 (en) 2004-11-24 2016-10-26 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
EP3025704B1 (en) 2005-03-10 2019-01-16 3M Innovative Properties Company Methods of reducing microbial contamination
US20070009531A1 (en) * 2005-07-06 2007-01-11 Branimir Sikic Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar
US20070010485A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
US20070010487A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
US20070010466A1 (en) * 2005-07-06 2007-01-11 Branimir Sikic Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer
PL2493474T3 (pl) * 2009-10-30 2020-03-31 Intratus, Inc. Sposoby i kompozycje do podtrzymywanego dostarczania leków
US20120022149A1 (en) * 2010-07-21 2012-01-26 Chowhan Masood A Pharmaceutical composition with enhanced solubility characteristics
EP2675275B1 (en) 2011-02-14 2017-12-20 The Regents Of The University Of Michigan Compositions and methods for the treatment of obesity and related disorders
HRP20200567T1 (hr) * 2011-11-29 2020-06-26 Jurox Pty Ltd Stabilni injektabilni farmaceutski pripravci koji sadrže 2-hidroksipropil-beta-ciklodekstrin i alfaksalon
US8946424B2 (en) 2013-05-02 2015-02-03 The Regents Of The University Of Michigan Deuterated amlexanox
EP3407974A4 (en) 2016-01-29 2019-08-28 The Regents Of The University Of Michigan Amlexanox Analogs
ES2914305T3 (es) * 2017-12-26 2022-06-09 Ind Tech Res Inst Composición para mejorar la solubilidad de sustancias poco solubles, uso de la misma y formulación compleja que contiene la misma

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD7498A1 (de) * 1951-02-20 1954-05-31 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung von haltbaren Lösungen in 1,3-Stellung substituierter Xanthine
JPS5831210B2 (ja) * 1973-04-09 1983-07-05 武田薬品工業株式会社 アンテイナスイセイケンダクエキノセイゾウホウ
JPS53111096A (en) * 1977-03-08 1978-09-28 Takeda Chem Ind Ltd 1-azaxanthone-3-carboxylic acid derivative and its preparation
CA1087188A (en) * 1977-03-08 1980-10-07 Hirosada Sugihara 1-azaxanthone-3-carboxylic acids
JPS54115398A (en) * 1978-02-27 1979-09-07 Takeda Chem Ind Ltd 1-azaxanthone-3-carboxylic acid derivative and its preparation
JPS6042766B2 (ja) * 1978-12-09 1985-09-25 日本化薬株式会社 基剤
ZA815175B (en) * 1980-08-01 1982-09-29 Smith & Nephew Ass Pharmaceutical composition
JPS57200361A (en) * 1981-06-03 1982-12-08 Sumitomo Chem Co Ltd "indomethacin(r)" pharmaceutical with low irritant action
JPS58126810A (ja) * 1981-12-24 1983-07-28 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法
JPS58174310A (ja) * 1982-04-06 1983-10-13 Wakamoto Pharmaceut Co Ltd 抗炎症点眼剤
DE3372705D1 (en) * 1982-04-30 1987-09-03 Takeda Chemical Industries Ltd Pharmaceutical composition and its use
US4539326A (en) * 1982-08-20 1985-09-03 Takeda Chemical Industries, Ltd. 5-Oxo-5H-(1)benzopyrano(2,3-b)pyridine derivatives, their production and use as anti-inflammatory agents
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
JPS59152320A (ja) * 1983-02-17 1984-08-31 Takeda Chem Ind Ltd 水性製剤
KR920010047B1 (ko) * 1985-01-28 1992-11-13 다께다야꾸힝고오교 가부시끼가이샤 2-아미노-5-옥소-5H-[1]벤조피라노[2,3-b]피리딘-3-카르복실산 유도체의 제조방법

Also Published As

Publication number Publication date
NO171005B (no) 1992-10-05
IE862214L (en) 1987-02-19
IE59425B1 (en) 1994-02-23
CA1269618A (en) 1990-05-29
EP0213514A3 (en) 1987-07-22
NO171005C (no) 1993-01-13
DE3672097D1 (de) 1990-07-26
JPS62123116A (ja) 1987-06-04
JPH0478614B2 (da) 1992-12-11
MY102075A (en) 1992-03-31
DK166757B1 (da) 1993-07-12
NO863253D0 (no) 1986-08-12
EP0213514A2 (en) 1987-03-11
US4728509A (en) 1988-03-01
EP0213514B1 (en) 1990-06-20
DK379986A (da) 1987-02-20
NO863253L (no) 1987-02-20
ATE53944T1 (de) 1990-07-15

Similar Documents

Publication Publication Date Title
DK379986A (da) Flydende vandigt praeparat af en 2-amino-5-oxo-5h-(1)-benzopyran(2,3-b)-pyridin-3-karboxylsyre
IL148516A (en) Retroviral protease inhibiting compound
ATE239752T1 (de) Pyrimidinderivate als markierte bindungspartner
ES2044836T3 (es) Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene.
NO965305L (no) Nye forbindelser, fremgangsmåter ved deres fremstilling og anti-tumormidler
PT83104B (en) Novel guanidinomethylbenzoic acid derivatives
DK328188A (da) Pyridinderivater, deres fremstilling og laegemidler indeholdende forbindelserne
DK322588A (da) Cycloalkylamider af 6-substituerede (8beta)-1-alkylergoliner og fremgangsmaade til fremstilling af saadanne forbindelser
MA20968A1 (fr) Compositions bactericides a base de derives de l'acide phosphoreux
IE46288L (en) 4,5,6,7-TETRAHYDRO-THIENO [2,3-c] AND [3,2-c] PYRIDINES
DK282285D0 (da) Hidtil ukendte 8-alkylthio-2-piperazino-pyrimido(5,4-d)pyrimidiner,deres fremstilling og laegemidler indeholdende disse forbindelser
DK240283D0 (da) Beta-carbolin-3-carboxylsyrederivater og fremgangsmade til fremstilling af samme
ES524524A0 (es) Procedimiento para la preparacion de un aducto de un diisocianato
AU590793B2 (en) Phenoxy pthalide derivatives
ES517779A0 (es) Procedimiento de preparacion de nuevos derivados de 2-fenilmorfolina.
PT88374A (pt) Process for the preparation of diphenyl ether herbicides
EP0312245A3 (en) Polycyclic compounds and pharmaceutical compositions thereof
DE69016224D1 (de) Verfahren zur Herstellung von Lactamderivaten.
KR860007876A (ko) 제초제 조성물
JPS52122387A (en) 7alpha-methoxycephalosporin derivatives and their preparation
JPS52130820A (en) Production of tetrachloronaphthalic acid derivative
JPS52139091A (en) Preparation of isooxazoro(3,4-d)pyrimidine derivatives
ATE77373T1 (de) Verfahren zur herstellung von chinolinsaeurederivaten.
JPS5337630A (en) Phenoxyphenoxyvaleric acid derivatives and heribicides containing them
ES8304546A1 (es) Un procedimiento de preparacion de zomepirac y sus analogos.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed